tailieunhanh - A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease that lack of effective therapeutic drugs. K-001 is an oral antitumor drug made from active ingredients of marine microorganisms. The current study aimed to evaluate safety and antitumor activity of K-001 in patients with advanced PDAC. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN